• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在北美患者的硬斑病、硬皮病或硬化萎缩性苔藓的皮肤病变中,聚合酶链反应检测不到伯氏疏螺旋体DNA。

Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America.

作者信息

Dillon W I, Saed G M, Fivenson D P

机构信息

Department of Dermatology, Henry Ford Health Sciences Center, Detroit, MI, USA.

出版信息

J Am Acad Dermatol. 1995 Oct;33(4):617-20. doi: 10.1016/0190-9622(95)91281-9.

DOI:10.1016/0190-9622(95)91281-9
PMID:7673495
Abstract

BACKGROUND

Borrelia burgdorferi has been linked to the pathogenesis of morphea and lichen sclerosus et atrophicus (LSA). However, considerable controversy still exists as to the actual role, if any, that this spirochete plays in the development of these diseases. Antibody titer determinations have been inconclusive and polymerase chain reaction (PCR) studies have yielded conflicting results.

OBJECTIVE

We sought to show whether PCR analysis detected B. burgdorferi in archival tissue specimens from the involved skin of 20 North American patients with morphea, 10 patients with LSA, and four patients with scleroderma.

METHODS

We used two different sets of PCR primers for the B. burgdorferi flagellin gene, one specific for European strains of B. burgdorferi, and another common to both European and American strains. A subset of these samples were further amplified with nested PCR primers.

RESULTS

None of the samples showed PCR products with either primer sets, whereas purified B. burgdorferi DNA and lesional erythema chronicum migrans tissues, which were used as positive controls, yielded easily detectable products with all primer sets.

CONCLUSION

These data suggest that B. burgdorferi infection plays no role in the development of morphea, LSA, or scleroderma in North American patients; these findings further support the recent observations that B. burgdorferi strain variability is associated with differential spectra of disease in North America compared with that found in various parts of Europe.

摘要

背景

伯氏疏螺旋体与硬斑病和萎缩性硬化性苔藓(LSA)的发病机制有关。然而,关于这种螺旋体在这些疾病发展中实际所起的作用(如果有作用的话)仍存在相当大的争议。抗体滴度测定结果尚无定论,聚合酶链反应(PCR)研究也得出了相互矛盾的结果。

目的

我们试图表明PCR分析能否在20例北美硬斑病患者、10例LSA患者和4例硬皮病患者受累皮肤的存档组织标本中检测到伯氏疏螺旋体。

方法

我们使用了两组不同的针对伯氏疏螺旋体鞭毛蛋白基因的PCR引物,一组对欧洲伯氏疏螺旋体菌株具有特异性,另一组对欧洲和美国菌株均通用。这些样本的一个子集用巢式PCR引物进一步扩增。

结果

所有样本用任何一组引物均未显示出PCR产物,而用作阳性对照的纯化伯氏疏螺旋体DNA和病灶性慢性游走性红斑组织,用所有引物组均产生了易于检测到的产物。

结论

这些数据表明,伯氏疏螺旋体感染在北美患者硬斑病、LSA或硬皮病的发展中不起作用;这些发现进一步支持了最近的观察结果,即与欧洲各地发现的情况相比,北美伯氏疏螺旋体菌株的变异性与不同的疾病谱相关。

相似文献

1
Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America.在北美患者的硬斑病、硬皮病或硬化萎缩性苔藓的皮肤病变中,聚合酶链反应检测不到伯氏疏螺旋体DNA。
J Am Acad Dermatol. 1995 Oct;33(4):617-20. doi: 10.1016/0190-9622(95)91281-9.
2
Detection of Borrelia burgdorferi DNA (B garinii or B afzelii) in morphea and lichen sclerosus et atrophicus tissues of German and Japanese but not of US patients.在德国和日本患者的硬斑病及硬化萎缩性苔藓组织中检测到伯氏疏螺旋体DNA(伽氏疏螺旋体或阿氏疏螺旋体),而在美国患者中未检测到。
Arch Dermatol. 1997 Jan;133(1):41-4.
3
Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification.通过DNA扩增证实硬斑病和萎缩性硬化性苔藓中存在伯氏疏螺旋体感染的进一步证据。
J Invest Dermatol. 1993 May;100(5):717-20. doi: 10.1111/1523-1747.ep12472369.
4
Role of Borrelia burgdorferi in the pathogenesis of morphea/scleroderma and lichen sclerosus et atrophicus: a PCR study of thirty-five cases.伯氏疏螺旋体在硬斑病/硬皮病和硬化萎缩性苔藓发病机制中的作用:35例病例的聚合酶链反应研究
J Cutan Pathol. 1996 Aug;23(4):350-8. doi: 10.1111/j.1600-0560.1996.tb01309.x.
5
Evidence for Borrelia burgdorferi in morphea and lichen sclerosus.伯氏疏螺旋体在硬斑病和硬化性苔藓中的证据。
Int J Dermatol. 2000 Apr;39(4):278-83. doi: 10.1046/j.1365-4362.2000.00912.x.
6
No evidence for Borrelia burgdorferi infection in lesions of morphea and lichen sclerosus et atrophicus in Spain. A prospective study and literature review.西班牙硬斑病和萎缩性硬化性苔藓皮损中无伯氏疏螺旋体感染证据:一项前瞻性研究及文献综述
Acta Derm Venereol. 1997 Jul;77(4):299-304. doi: 10.2340/0001555577299304.
7
Successful amplification of DNA specific for Finnish Borrelia burgdorferi isolates in erythema chronicum migrans but not in circumscribed scleroderma lesions.成功扩增出针对芬兰伯氏疏螺旋体分离株的DNA,该DNA存在于慢性游走性红斑中,但不存在于局限性硬皮病病变中。
J Invest Dermatol. 1994 Mar;102(3):339-45. doi: 10.1111/1523-1747.ep12371793.
8
Is morphoea caused by Borrelia burgdorferi? A review.莱姆病螺旋体是否会引发硬斑病?一篇综述。
Br J Dermatol. 2000 Apr;142(4):636-44. doi: 10.1046/j.1365-2133.2000.03407.x.
9
Borrelia in granuloma annulare, morphea and lichen sclerosus: a PCR-based study and review of the literature.环状肉芽肿、硬斑病和硬化性苔藓中的疏螺旋体:一项基于聚合酶链反应的研究及文献综述
J Cutan Pathol. 2010 May;37(5):571-7. doi: 10.1111/j.1600-0560.2009.01493.x. Epub 2009 Dec 10.
10
Spirochetal forms in the dermal lesions of morphea and lichen sclerosus et atrophicus.硬斑病和萎缩性硬化性苔藓皮肤损害中的螺旋体形态。
Am J Dermatopathol. 1990 Aug;12(4):357-62. doi: 10.1097/00000372-199008000-00005.

引用本文的文献

1
Immunologic and nonimmunologic sclerodermal skin conditions - review.免疫性和非免疫性硬皮病皮肤状况——综述。
Front Immunol. 2023 Jul 12;14:1180221. doi: 10.3389/fimmu.2023.1180221. eCollection 2023.
2
Development of minimum standards of care for juvenile localized scleroderma.制定青少年局限性硬皮病最低护理标准。
Eur J Pediatr. 2018 Jul;177(7):961-977. doi: 10.1007/s00431-018-3144-8. Epub 2018 May 4.
3
Morphea and Eosinophilic Fasciitis: An Update.硬斑病和嗜酸性筋膜炎:最新进展
Am J Clin Dermatol. 2017 Aug;18(4):491-512. doi: 10.1007/s40257-017-0269-x.
4
Systemic sclerosis and localized scleroderma--current concepts and novel targets for therapy.系统性硬化症和局限性硬皮病——当前概念及新的治疗靶点
Semin Immunopathol. 2016 Jan;38(1):87-95. doi: 10.1007/s00281-015-0551-z. Epub 2015 Nov 17.
5
Frequency of Borrelia in Morphea Lesion by Polymerase Chain Reaction in Northeast of Iran.伊朗东北部硬斑病皮损中伯氏疏螺旋体的聚合酶链反应检测频率
Jundishapur J Microbiol. 2015 Aug 27;8(8):e19730. doi: 10.5812/jjm.19730v2. eCollection 2015 Aug.
6
Progressive hemifacial atrophy: a review.进行性半侧颜面萎缩:综述
Orphanet J Rare Dis. 2015 Apr 1;10:39. doi: 10.1186/s13023-015-0250-9.
7
Borrelia burgdorferi Infections in the United States.美国的伯氏疏螺旋体感染
J Clin Aesthet Dermatol. 2012 Aug;5(8):18-28.
8
Systemic and localized scleroderma in children: current and future treatment options.儿童系统性和局限性硬皮病:当前及未来的治疗选择
Paediatr Drugs. 2006;8(2):85-97. doi: 10.2165/00148581-200608020-00002.
9
Morphoea and Borrelia burgdorferi: results from the Scottish Highlands in the context of the world literature.硬斑病与伯氏疏螺旋体:基于世界文献背景下的苏格兰高地研究结果
Mol Pathol. 2002 Dec;55(6):374-8. doi: 10.1136/mp.55.6.374.
10
PCR in laboratory diagnosis of human Borrelia burgdorferi infections.聚合酶链反应在人类伯氏疏螺旋体感染实验室诊断中的应用
Clin Microbiol Rev. 1997 Jan;10(1):185-201. doi: 10.1128/CMR.10.1.185.